REPRODUCTIVE ENDOCRINOLOGY Metformin or thiazolidinedione therapy in PCOS?

被引：1

作者：

Grover, Anjali ^{[1
]}

Yialamas, Maria A. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

来源：

NATURE REVIEWS ENDOCRINOLOGY | 2011年 / 7卷 / 03期

关键词：

POLYCYSTIC-OVARY-SYNDROME; WOMEN; CLOMIPHENE; PREVALENCE; OVULATION;

D O I：

10.1038/nrendo.2011.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

insulin resistance has a key role in the pathogenesis of polycystic ovary syndrome, a common endocrinopathy that affects young women. Therefore, the use of insulin-sensitizing agents has been studied extensively in this patient population. given the effectiveness of metformin and thiazolidinediones in previous studies, the question arises: is one class better than the other?

引用

页码：128 / 129

页数：3

共 10 条

[1] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].

Apridonidze, T ;

Essah, PA ;

Iuorno, MJ ;

Nestler, JE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935

[2] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].

Azziz, R ;

Ehrmann, D ;

Legro, RS ;

Whitcomb, RW ;

Hanley, R ;

Fereshetian, AG ;

O'Keefe, M ;

Ghazzi, MN .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632

[3] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].

Chang, J ;

Azziz, R ;

Legro, R ;

Dewailly, D ;

Franks, S ;

Tarlatzis, BC ;

Fauser, B ;

Balen, A ;

Bouchard, P ;

Dahlgren, E ;

Devoto, L ;

Diamanti, E ;

Dunaif, A ;

Filicori, M ;

Homburg, R ;

Ibanez, L ;

Laven, J ;

Magoffin, D ;

Nestler, J ;

Norman, RJ ;

Pasquali, R ;

Pugeat, M ;

Strauss, J ;

Tan, S ;

Taylor, A ;

Wild, R ;

Wild, S ;

Ehrmann, D ;

Lobo, R .

FERTILITY AND STERILITY, 2004, 81 (01) :19-25

[4] Medical progress: Polycystic ovary syndrome [J].

Ehrmann, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1223-1236

[5] Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].

Ehrmann, DA ;

Barnes, RB ;

Rosenfield, RL ;

Cavaghan, MK ;

Imperial, J .

DIABETES CARE, 1999, 22 (01) :141-146

[6] Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome [J].

Legro, Richard S. ;

Barnhart, Huiman X. ;

Schlaff, William D. ;

Carr, Bruce R. ;

Diamond, Michael P. ;

Carson, Sandra A. ;

Steinkampf, Michael P. ;

Coutifaris, Christos ;

McGovern, Peter G. ;

Cataldo, Nicholas A. ;

Gosman, Gabriella G. ;

Nestler, John E. ;

Giudice, Linda C. ;

Leppert, Phyllis C. ;

Myers, Evan R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (06) :551-566

[7] Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis [J].

Li, X-J ;

Yu, Y-X ;

Liu, C-Q ;

Zhang, W. ;

Zhang, H-J ;

Yan, B. ;

Wang, L-Y ;

Yang, S-Y ;

Zhang, S-H .

CLINICAL ENDOCRINOLOGY, 2011, 74 (03) :332-339

[8] Metformin in polycystic ovary syndrome: systematic review and meta-analysis [J].

Lord, JM ;

Flight, IHK ;

Norman, RJ .

BRITISH MEDICAL JOURNAL, 2003, 327 (7421) :951-955

[9] Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome [J].

Nestler, JE ;

Jakubowicz, DJ ;

Evans, WS ;

Pasquali, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (26) :1876-1880

[10] Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome [J].

Ortega-González, C ;

Luna, S ;

Hernández, L ;

Crespo, G ;

Aguayo, P ;

Arteaga-Troncoso, G ;

Parra, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1360-1365

← 1 →